Literature DB >> 24146002

Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first century.

Jordi Rello1, Bárbara Borgatta, Thiago Lisboa.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24146002     DOI： 10.1007/s00134-013-3046-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors.

Authors:  Ignacio Martin-Loeches; Maria Deja; Despoina Koulenti; George Dimopoulos; Brian Marsh; Antonio Torres; Michael S Niederman; Jordi Rello
Journal:  Intensive Care Med       Date:  2013-01-29       Impact factor: 17.440

2.  Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa.

Authors:  J Rello; P Jubert; J Vallés; A Artigas; M Rué; M S Niederman
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

3.  Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms.

Authors:  J L Trouillet; A Vuagnat; A Combes; N Kassis; J Chastre; C Gibert
Journal:  Clin Infect Dis       Date:  2002-03-15       Impact factor: 9.079

4.  Identifying new risk factors for Pseudomonas aeruginosa pneumonia in intensive care units: experience of the French national surveillance, REA-RAISIN.

Authors:  A G Venier; D Gruson; T Lavigne; P Jarno; F L'hériteau; B Coignard; A Savey; A M Rogues
Journal:  J Hosp Infect       Date:  2011-07-07       Impact factor: 3.926

5.  Optimization of meropenem dosage in the critically ill population based on renal function.

Authors:  Jared L Crandon; Robert E Ariano; Sheryl A Zelenitsky; Anthony M Nicasio; Joseph L Kuti; David P Nicolau
Journal:  Intensive Care Med       Date:  2010-12-07       Impact factor: 17.440

6.  Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms.

Authors:  O Leroy; T d'Escrivan; P Devos; L Dubreuil; E Kipnis; H Georges
Journal:  Infection       Date:  2005-06       Impact factor: 3.553

7.  Hospital-acquired pneumonia: risk factors for antimicrobial-resistant causative pathogens in critically ill patients.

Authors:  Olivier Leroy; Sandrine Jaffré; Thibaud D'Escrivan; Patrick Devos; Hugues Georges; Serge Alfandari; Gilles Beaucaire
Journal:  Chest       Date:  2003-06       Impact factor: 9.410

8.  International study of the prevalence and outcomes of infection in intensive care units.

Authors:  Jean-Louis Vincent; Jordi Rello; John Marshall; Eliezer Silva; Antonio Anzueto; Claude D Martin; Rui Moreno; Jeffrey Lipman; Charles Gomersall; Yasser Sakr; Konrad Reinhart
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

9.  Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients.

Authors:  Mario Tumbarello; Gennaro De Pascale; Enrico Maria Trecarichi; Teresa Spanu; Federica Antonicelli; Riccardo Maviglia; Mariano Alberto Pennisi; Giuseppe Bello; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2013-02-01       Impact factor: 17.440

10.  Risk factors for ventilator-associated pneumonia: from epidemiology to patient management.

Authors:  Marc J M Bonten; Marin H Kollef; Jesse B Hall
Journal:  Clin Infect Dis       Date:  2004-03-30       Impact factor: 9.079
View more
  7 in total

1.  Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study.

Authors:  Mohammed J Al-Jaghbeer; Julie Ann Justo; William Owens; Joseph Kohn; P Brandon Bookstaver; Jennifer Hucks; Majdi N Al-Hasan
Journal:  Infection       Date:  2018-05-11       Impact factor: 3.553

2.  COPD patients with ventilator-associated pneumonia: implications for management.

Authors:  D Koulenti; S Blot; J M Dulhunty; L Papazian; I Martin-Loeches; G Dimopoulos; C Brun-Buisson; M Nauwynck; C Putensen; J Sole-Violan; A Armaganidis; J Rello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-25       Impact factor: 3.267

3.  Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia.

Authors:  Xiaoliang Liang; Kushagra Gupta; Joselyn Rojas Quintero; Manuela Cernadas; Lester Kobzik; Helen Christou; Gerald B Pier; Caroline A Owen; Sule Çataltepe
Journal:  FASEB J       Date:  2018-11-21       Impact factor: 5.834

Review 4.  Pseudomonas aeruginosa ventilator-associated pneumonia management.

Authors:  Sergio Ramírez-Estrada; Bárbara Borgatta; Jordi Rello
Journal:  Infect Drug Resist       Date:  2016-01-20       Impact factor: 4.003

5.  Necrotizing Pseudomonas aeruginosa Community-Acquired Pneumonia: A Case Report and Review of the Literature.

Authors:  Satish Maharaj; Carmen Isache; Karan Seegobin; Simone Chang; Grant Nelson
Journal:  Case Rep Infect Dis       Date:  2017-05-17

6.  Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics.

Authors:  Jean-Francois Timsit; Giuseppe Citerio; Jan Bakker; Matteo Bassetti; Dominique Benoit; Maurizio Cecconi; J Randall Curtis; Glenn Hernandez; Margaret Herridge; Samir Jaber; Michael Joannidis; Laurent Papazian; Mark Peters; Pierre Singer; Martin Smith; Marcio Soares; Antoni Torres; Antoine Vieillard-Baron; Elie Azoulay
Journal:  Intensive Care Med       Date:  2014-02-12       Impact factor: 17.440

7.  Combination Therapy of Polymyxin B and Amikacin for Community-Acquired Pseudomonas aeruginosa Pneumonia with MODS in a Previously Healthy Patient: A Case Report.

Authors:  Junyu Wang; Lu Yun; Hong Zhao; Xiangpeng Li
Journal:  Infect Drug Resist       Date:  2021-07-27       Impact factor: 4.003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.